Azithromycin, like other macrolides, can prolong the QT interval, increasing the risk of a potentially fatal arrhythmia called torsades de pointes. This risk is heightened in individuals with pre-existing cardiac conditions.
Patients with congenital long QT syndrome should avoid azithromycin. The same precaution applies to those with a history of QT prolongation or torsades de pointes.
Individuals taking medications known to prolong the QT interval (such as certain antiarrhythmics, antipsychotics, and antidepressants) should discuss azithromycin use with their physician. Careful monitoring, including an electrocardiogram (ECG), may be necessary.
Patients with bradycardia (slow heart rate), hypokalemia (low potassium levels), or hypomagnesemia (low magnesium levels) face an elevated risk of QT prolongation when taking azithromycin. These electrolyte imbalances should be addressed before initiating azithromycin therapy.
Severe heart failure also increases the risk. Consult your doctor if you have heart failure before taking azithromycin.
Always inform your doctor and pharmacist of all medications you are taking, including over-the-counter drugs and herbal supplements, to minimize the risk of drug interactions and adverse effects.
